Company Stock Information

Company Stock Data | Company Summary in Chinese | Company Press Release (135) | NAI Interview(0) | Company Event(0) | Research Report (0) | Chinese Micro Site | Contact Company
CELL THERAPEUTICS INC (NASDAQ:CTIC)
Show Interactive Chart | Add to Portfolio

Stock Info

Last Trade 1.460
Change 0.000
Change (%) 0%
Volume 672,159
10 Days Avg Vol 2,615,500
3 Months Avg Vol 3,728,200
52 Weeks Lo/Hi $ 0.97 - $ 4.25
YTD Price Gain % 60.2%
10 Wks Moving Avg $ 3
200 Days Moving Avg $ 2
Liquidity Ratio 2,784,300
Market Cap 458,480,189

Related News

TitleDate
Cell Therapeutics, Inc. Announces Change of Name to CTI BioPharma Corp.05/29/2014
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts03/02/2014
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts03/02/2014
Cell Therapeutics Appoints Karen Ignagni to Board of Directors02/02/2014

Summary

Contact Info

Cell Therapeutics's address Cell Therapeutics
Suite 600 - 3101 Western Avenue
Seattle WA 98121
Cell Therapeutics's Telephne number (206) 282-7100
Cell Therapeutics's fax number (206) 284-6206
Cell Therapeutics's email account invest@ctiseattle.com
Cell Therapeutics's web site www.celltherapeutics.com
Dr. James A. Bianco,M.D.